MDSpire - Summary
Feature

Decoding Idiopathic Intracranial Hypertension

Marc Bouffard discusses Mass General Brigham’s recently launched initiative aimed at better understanding idiopathic intracranial hypertension

Share

A recent study from the Journal of Neuro-Ophthalmology highlights DTI-ALPS as a promising noninvasive method for diagnosing idiopathic intracranial hypertension (IIH) by assessing fluid flow in the glymphatic system. Funded by the IIH Research and Treatment Initiative at Mass General Brigham, the research aims to address current diagnostic challenges and explore more effective treatments for IIH, a condition predominantly affecting overweight women of childbearing age. The findings point toward the possibility of ALPS-indices becoming reliable biomarkers, helping to clarify the complex nature of IIH and reduce misdiagnoses.

Original Source(s)

Decoding Idiopathic Intracranial Hypertension

  • by Alun Evans

  • March 30, 2026

Related Content

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min
Farid Takes Helm of Aurion MAB

Aurion Biotech names Marjan Farid chair of medical advisory board

  • March 27, 2026

  • 2 min
Why Proactive Dry Eye Care Should Be the New Standard

The dental profession long ago decided it was important to preach preventative maintenance for everyone. We should do the same